Predicting relapse in chronic spontaneous urticaria: A retrospective cohort study evaluating omalizumab withdrawal regimens.

Kucharczyk, Aleksandra; Marczyk, Katarzyna; Kucharczyk, Barbara; Plisko, Robert; Perkowska, Jolanta; Owczarek, Witold; Jahnz-Rózyk, Karina

Kucharczyk, Aleksandra; Marczyk, Katarzyna; Kucharczyk, Barbara; Plisko, Robert; Perkowska, Jolanta; Owczarek, Witold; Jahnz-Rózyk, Karina.

Afiliação

Kucharczyk A; Department of Internal Diseases, Pneumonology, Allergology and Clinical Immunology, Military Institute of Medicine - National Research Institute, Warszawa, Poland.
Marczyk K; Department of Internal Diseases, Pneumonology, Allergology and Clinical Immunology, Military Institute of Medicine - National Research Institute, Warszawa, Poland.
Kucharczyk B; Medical Faculty I, Medical University of Warsaw, Warszawa, Poland.
Plisko R; HTA Consulting, Kraków, Poland.
Perkowska J; Department of Infectious Diseases and Allergology, Military Institute of Medicine - National Research Institute, Warszawa, Poland.
Owczarek W; Department of Dermatology, Military Institute of Medicine - National Research Institute, Warszawa, Poland.
Jahnz-Rózyk K; Department of Internal Diseases, Pneumonology, Allergology and Clinical Immunology, Military Institute of Medicine - National Research Institute, Warszawa, Poland.

Allergy ; 2024 Jun 24.

Article em En | MEDLINE | ID: mdl-38922945

Palavras-chave

chronic spontaneous urticaria; omalizumab; relapse; risk factors; withdrawal

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Allergy Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Polônia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google